Search Within

Ronald P DeMatteo

  1. "Sarcoma Service"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (5)
  3. Research Letter (1)
Groups
  1. Department of Medicine (15)
  2. Sarcoma Service (15)
  3. Solid Tumor Oncology Division (15)
  4. Surgery (15)
  5. GSK Faculty (13)
  6. Human Oncology and Pathogenesis Program (13)

More Groups

People
  1. William Tap (14)
  2. Cristina Antonescu (10)
  3. Samuel Singer (9)
  4. Mary Keohan (8)
  5. Vinod Balachandran (7)
  6. Michael Cavnar (6)

More People

Years
  1. 2021 (2)
  2. 2019 (3)
  3. 2018 (1)
  4. 2017 (3)
  5. 2016 (1)
  6. 2015 (2)

More Years

Publications
  1. Annals of Surgical Oncology (4)
  2. Journal of Clinical Oncology (3)
  3. Annals of Surgery (2)
  4. Clinical Cancer Research (2)
  5. Investigational New Drugs (1)
  6. Journal of Gastrointestinal Surgery (1)

More Publications

Publishers
  1. Springer (6)
  2. American Society of Clinical Oncology (3)
  3. American Association for Cancer Research (2)
  4. Lippincott Williams & Wilkins (2)
  5. Elsevier Science, Inc. (1)
  6. Nature Publishing Group (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors after neoadjuvant imatinib for newly diagnosed primary gastrointestinal stromal tumor
    Journal Article

    Cavnar, M. J.; Seier, K.; Gönen, M.; Curtin, C.; Balachandran, V. P.; Tap, W. D.; Antonescu, C. R.; Singer, S.; DeMatteo, R. P.
    Journal of Gastrointestinal Surgery (2021)

    Fulltext@MSK | Save
  • Outcome of 1000 patients with gastrointestinal stromal tumor (GIST) treated by surgery in the pre- and post-imatinib eras
    Journal Article

    Cavnar, M. J.; Seier, K.; Curtin, C.; Balachandran, V. P.; Coit, D. G.; Yoon, S. S.; Crago, A. M.; Strong, V. E.; Tap, W. D.; Gönen, M.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Tumor mitotic rate after neoadjuvant imatinib is associated with outcome in primary gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Cavnar, M. J.; Seier, K.; Mithat, G.; Balachandran, V. P.; Curtin, C.; Keohan, M.; Tap, W.; Antonescu, C.; Singer, S.; DeMatteo, R. P.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Cytoreductive surgery for metastatic gastrointestinal stromal tumors treated with tyrosine kinase inhibitors: A 2-institutional analysis
    Journal Article

    Fairweather, M.; Balachandran, V. P.; Li, G. Z.; Bertagnolli, M. M.; Antonescu, C.; Tap, W.; Singer, S.; DeMatteo, R. P.; Raut, C. P.
    Annals of Surgery (2018)

    Fulltext@MSK | Save
  • The clinical impact of performing routine next generation sequencing (NGS) in gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Vonya, T.; Yoon, S. S.; Singer, S.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Rectal gastrointestinal stromal tumor (GIST) in the era of imatinib: Organ preservation and improved oncologic outcome
    Journal Article

    Cavnar, M. J.; Wang, L.; Balachandran, V. P.; Antonescu, C. R.; Tap, W. D.; Keohan, M.; Singer, S.; Temple, L.; Nash, G. M.; Weiser, M. R.; more...
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Combined KIT and CTLA-4 blockade in patients with refractory GIST and other advanced sarcomas: A phase Ib study of dasatinib plus ipilimumab
    Journal Article

    D'Angelo, S. P.; Shoushtari, A. N.; Keohan, M. L.; Dickson, M. A.; Gounder, M. M.; Chi, P.; Loo, J. K.; Gaffney, L.; Schneider, L.; Patel, Z.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Chronic imatinib (> 3 years) therapy after complete resection of primary, high-risk gastrointestinal stromal tumor (GIST) is associated with low recurrence
    Meeting Abstract

    Cavnar, M. J.; Balachandran, V. P.; Chi, P.; Keohan, M. L.; Tap, W. D.; DeMatteo, R. P.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save